CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleRevenue is $2.52B, above the global median of $548.88M
- FinancialsAltman Z-Score 2.26: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.80%Below 5Y avg (2.22%)
Annual Rate
CNY 0.20Paid annual
Payout Ratio
83.7%Moderate
Payback Period
53.6 yr
Last Ex-Dividend
Sep 24, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.48BCNY968.05M · vs all stocks (USD)
Trailing P/E
23.06xvs Pharmaceutical Retailers peers
Revenue (TTM)
16.89BCNY2.52B · vs all stocks (USD)
Profit Margin
1.60%vs Pharmaceutical Retailers peers
Beta
0.5690xvs all stocks
52-Week Change
-22.48%vs all stocks
Market Capitalization
6.48BCNY968.05M · vs all stocks (USD)
Enterprise Value
5.34BCNY796.79M · vs all stocks (USD)
Trailing P/E
23.06xvs Pharmaceutical Retailers peers
Forward P/E
12.02xvs Pharmaceutical Retailers peers
Price to Sales (TTM)
0.3838xvs Pharmaceutical Retailers peers
Price to Book (MRQ)
0.8536xvs Pharmaceutical Retailers peers
Enterprise to Revenue
0.3160xvs Pharmaceutical Retailers peers
Enterprise to EBITDA
8.66xvs Pharmaceutical Retailers peers
Gross Margin
33.39%vs Pharmaceutical Retailers peers
Profit Margin
1.60%vs Pharmaceutical Retailers peers
Operating Margin
2.13%vs Pharmaceutical Retailers peers
Return on Assets (TTM)
2.06%vs Pharmaceutical Retailers peers
Return on Equity (TTM)
3.62%vs Pharmaceutical Retailers peers
Revenue (TTM)
16.89BCNY2.52B · vs all stocks (USD)
Revenue per Share (TTM)
29.60CNYUpdated Sep 21, 2026Quarterly Revenue Growth
-2.80%vs Pharmaceutical Retailers peers
Gross Profit (TTM)
5.43BCNY811.44M · vs all stocks (USD)
EBITDA (TTM)
777.57MCNY116.11M · vs all stocks (USD)
Net Income (TTM)
270.63MCNY40.41M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-9.50%vs Pharmaceutical Retailers peers
Operating Cash Flow (TTM)
1.98BCNY295.31M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.56BCNY232.80M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.2000CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
1.80%vs all stocks
5-Year Average Dividend Yield
2.22%vs all stocks
Payout Ratio
83.65%vs Pharmaceutical Retailers peers
Minority Interest (Equity)
153.84MCNYFY2025 · Dec 31, 2025Revenue
17.34BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
11.68BCNYFY2025 · Dec 31, 2025Gross Profit
5.66BCNYFY2025 · Dec 31, 2025Operating Income
745.35MCNY111.30M · vs all stocks (USD)
Pre-tax Income
406.59MCNYFY2025 · Dec 31, 2025Income Tax Expense
134.89MCNYFY2025 · Dec 31, 2025Net Income
271.71MCNYFY2025 · Dec 31, 2025EBIT
539.82MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.99BCNYFY2025 · Dec 31, 2025Research & Development
10.59MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
746.70MCNYFY2025 · Dec 31, 2025Other Operating Expenses
63.57MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
21.02MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
133.22MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4571CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4571CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
576.31MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
576.31MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
271.71MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-8.27MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
812.00MCNYFY2025 · Dec 31, 2025Free Cash Flow
534.06MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.52BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
271.71MCNYFY2025 · Dec 31, 2025Other Non-cash Items
306.09MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-23.40MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
257.59MCNYFY2025 · Dec 31, 2025Capital Expenditures
-277.94MCNYFY2025 · Dec 31, 2025Net Acquisitions
2.68MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.91BCNYFY2025 · Dec 31, 2025Sale of Investments
3.24BCNYFY2025 · Dec 31, 2025Other Investing Activity
-80.48MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-25.54MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
745.20MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-721.07MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-304.89MCNYFY2025 · Dec 31, 2025Other Financing Charges
-1.26BCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-1.54BCNYFY2025 · Dec 31, 2025Shares Outstanding
585.60MSharesUpdated Sep 21, 2026Float Shares
315.51MSharesUpdated Sep 21, 2026% Held by Insiders
48.12%vs all stocks
% Held by Institutions
7.18%vs all stocks
Total Cash (MRQ)
3.47BCNY517.62M · vs all stocks (USD)
Total Cash per Share (MRQ)
6.04CNYUpdated Sep 21, 2026Total Debt (MRQ)
2.42BCNY360.84M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3176xvs Pharmaceutical Retailers peers
Current Ratio (MRQ)
1.35xvs Pharmaceutical Retailers peers
Book Value per Share (MRQ)
12.97CNYUpdated Sep 21, 2026Total Assets
15.61BCNY2.33B · vs all stocks (USD)
Total Current Assets
8.95BCNYFY2025 · Dec 31, 2025Total Liabilities
8.15BCNYFY2025 · Dec 31, 2025Total Non-current Assets
6.66BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.29BCNYFY2025 · Dec 31, 2025Total Current Liabilities
6.86BCNYFY2025 · Dec 31, 2025Cash
1.52BCNYFY2025 · Dec 31, 2025Cash Equivalents
782.38MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.30BCNYFY2025 · Dec 31, 2025Other Short-term Investments
759.84MCNYFY2025 · Dec 31, 2025Accounts Receivable
1.36BCNYFY2025 · Dec 31, 2025Inventory
3.67BCNYFY2025 · Dec 31, 2025Accounts Payable
4.44BCNYFY2025 · Dec 31, 2025Short-term Debt
1.37BCNYFY2025 · Dec 31, 2025Other Current Liabilities
213.31MCNYFY2025 · Dec 31, 2025Long-term Debt
1.27BCNYFY2025 · Dec 31, 2025Common Stock (Book)
585.60MCNYFY2025 · Dec 31, 2025Retained Earnings
4.50BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
7.46BCNY1.11B · vs all stocks (USD)
Treasury Stock
150.00MCNYFY2025 · Dec 31, 202552-Week Low
9.41CNYUpdated Sep 21, 202652-Week High
14.80CNYUpdated Sep 21, 202652-Week Change
-22.48%vs all stocks
Beta
0.5690xvs all stocks
50-Day MA
11.40CNYUpdated Sep 21, 2026200-Day MA
12.29CNYUpdated Sep 21, 2026Avg 10-Day Volume
4.87MSharesUpdated Sep 21, 2026Avg 30-Day Volume
9.87MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.4800CNYUpdated Sep 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.26: grey zoneSignificant
Altman Z-Score: 2.26
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Revenue is $2.52B, above the global median of $548.88MNotable
Revenue (USD): 2,522,012,952.494Global Median: 548,883,780.48
Levered free cash flow is $232.8M, above the global median of $18.73MNotable
Levered free cash flow (USD): 232,795,521.038Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Chengdu Hongqi Chain Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
BLS International Ltd.
Tier 1FlowUnit ReplicationInterfaceRule
Genky Drugstores Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceRule
Aoki Holdings Inc.
Tier 1FlowUnit ReplicationRiskInterface
Oriental Holdings Berhad
Tier 1FlowUnit ReplicationInterfaceRisk
Anhui Huaren Health Pharmaceutical Co. Ltd.
Tier 1FlowUnit ReplicationProductionInterface
Shanghai Waigaoqiao Free Trade Zone Development Co. Ltd.
Tier 1FlowUnit ReplicationProductionInterface
Abdullah Al Othaim Markets
Tier 1FlowUnit ReplicationInterfaceProduction
Sanjiang Shopping Club Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
Grocery Outlet Holding Corp
Tier 1FlowUnit ReplicationInterfaceProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationClose Below 40W SMA With Profitability
Sportradar Group AG
1 interpretationClose Below 40W SMA With Profitability
Shanghai Taisheng Wind Power Equipment Co., Ltd.
1 interpretationClose Below 40W SMA With Profitability